norharman has been researched along with Lung Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad Khan, R; Al-Farhan, K; Alsalme, A; Casini, A; de Almeida, A; Ghazzali, M; Reedijk, J | 1 |
| Basu, S; Budina-Kolomets, A; Chatwichien, J; Murphy, ME; Winkler, JD | 1 |
2 other study(ies) available for norharman and Lung Neoplasms
| Article | Year |
|---|---|
Light-stable bis(norharmane)silver(I) compounds: synthesis, characterization and antiproliferative effects in cancer cells.
Topics: Carbolines; Cell Line, Tumor; Cell Proliferation; Harmine; Humans; Light; Lung Neoplasms; Proton Magnetic Resonance Spectroscopy; Silver; X-Ray Diffraction | 2014 |
PUMA-dependent apoptosis in NSCLC cancer cells by a dimeric β-carboline.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Carbolines; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Dimerization; Humans; Lung Neoplasms; Proto-Oncogene Proteins | 2016 |